Market Research Report
Pharmaceutical Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
|Published by||The Business Research Company||Product code||671918|
Delivery time: Inquiry
|Pharmaceutical Drugs Global Market Report 2020-30: Covid 19 Implications and Growth|
|Published: Pre-Order||Content info:||
‘Pharmaceutical Drugs Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for pharmaceutical drugs which play a critical role in the treatment of patients with Covid 19.
Where is the largest and fastest growing market for the pharmaceutical drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmaceutical Drugs Market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
1) By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Subsegments Covered: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals; Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products; Anemia And Other Blood Disorder Drugs; Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs; Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma); Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations
Companies Mentioned: Novartis AG; Sanofi S.A.; Pfizer Inc.; Gilead Sciences, Inc.; Johnson & Johnson
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, pharmaceutical drugs indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Metabolic Disorders Drugs
Musculoskeletal Disorders Drugs
Central Nervous System Drugs
Respiratory Diseases Drugs
Retail Pharmacies/ Drug Stores